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Abstract
The inflammatory milieu in the respiratory tract in cystic fibrosis (CF) has been linked to the defective expression of the
cystic transmembrane regulator (CFTR) in epithelial cells. Alveolar macrophages (AM), important contibutors to
inflammatory responses in the lung, also express CFTR. The present study analyzes the phenotype of human AM with
silenced CFTR. Expression of CFTR mRNA and the immature form of the CFTR protein decreased 100-fold and 5.2-fold,
respectively, in AM transfected with a CFTR specific siRNA (CFTR-siRNA) compared to controls. Reduction of CFTR
expression in AM resulted in increased secretion of IL-8, increased phosphorylation of NF-kB, a positive regulator of IL-8
expression, and decreased expression of IkB-a, the inhibitory protein of NF-kB activation. AM with silenced CFTR
expression also showed increased apoptosis. We hypothesized that caveolin-1 (Cav1), a membrane protein that is co-
localized with CFTR in lipid rafts and that is related to inflammation and apoptosis in macrophages, may be affected by
decreased CFTR expression. Messenger RNA and protein levels of Cav1 were increased in AM with silenced CFTR.
Expression and transcriptional activity of sterol regulatory element binding protein (SREBP), a negative transcriptional
regulator of Cav1, was decreased in AM with silenced CFTR, but total and free cholesterol mass did not change. These
findings indicate that silencing of CFTR in human AM results in an inflammatory phenotype and apoptosis, which is
associated to SREBP-mediated regulation of Cav1.
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Introduction
CF lung disease is characterized by exaggerated inflammation
even in the absence of detectable pathogens [1]. Studies related to
inflammation in CF have mostly focused on defective CFTR in
lung epithelial cells [2], but CFTR may also play an important role
in immune cells [3–12].
Alveolar macrophages (AM) serve as first line defense within the
respiratory tract, stimulate inflammation and recruit other cells of
the immune system [13]. It is not known if AM play a primary role
in CF lung disease. Increased numbers of AM were observed in
the CF fetal airways [14] and recently in infants with CF [15],
suggesting an involvement of AM in the early onset of
inflammation. Studies in CF knockout mice suggested a role for
CFTR in AM phagosomes and indicated that AM contribute
directly to the exaggerated inflammatory response [16,17].
Impaired clearance of apoptotic cells [18,19], decreased antigen
presentation, and T-cell stimulatory activity [20] have been
described in CF lung disease, that could suggest potential
functional abnormalities of AM in CF. However, studying the
role of CFTR in AM derived from CF lungs is challenging as it is
difficult to distinguish if the AM phenotype is primarily induced by
the defective expression of CFTR in the AM or induced by the
inflammatory milieu resulting from defective CFTR expression in
epithelial or other cells [18,19].
The enhanced inflammatory response in CF has been linked to
apoptosis, but the exact mechanisms have been unclear and the
results have been contradicting. Increased apoptosis was described
in tracheal and pancreatic CF cells [21–23]. This was accompa-
nied by an increase in inflammatory cytokines and NF-kB
activation, which suggested a common pathway for apoptosis
and inflammation in these cells. In contrast, a number of studies
relate CFTR expression to apopotosis [24–29]. These have linked
the lack of CFTR expression or expression of mutant CFTR in CF
to a proinflammatory and antiapoptotic phenotype [24–29].
Others did not see differences in apoptosis in airway epithelial
cells [30]. Furthermore, defective clearance of apoptotic cells in
the CF airways was reported to be factor to further trigger the
inflammation [18,19]. The apparent inconsistencies of these
findings could be related to the cell-type and apoptosis of AM in
CF could play a role in the inflammatory response.
Both, inflammation and apoptosis in macrophages, are
associated with caveolin 1 (Cav1) [31–33], a membrane protein
that has been reported to colocalize with CFTR in epithelial cells
[34]. Colocalization of CFTR and Cav1 has been proposed to
constitute an ‘‘internalization platform’’, necessary for appropriate
immune response to infection [34]. Cav1 could be a macrophage-
specific link between apoptosis and inflammation in CF. The
regulation of Cav1 expression is through sterol regulatory element
binding proteins (SREBPs), key transcription factors of cellular
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11004lipid homeostasis [35]. SREBP expression is primarily regulated by
cellular cholesterol [36]. This relevant for CF as CFTR
dysfunction has been shown to affect cellular cholesterol and
SREBP [37–41]. Furthermore, alterations in cellular cholesterol
may play a role in the inflammatory phenotype in CF [37,40].
The goal of this study was (1) to analyze if decreased CFTR
expression in human AM affects inflammation and apoptosis by
using unstimulated AM derived from non-CF subjects with
silenced CFTR expression; (2) to focus on Cav 1 and its regulation
by SREBP as a potential factor. We found that silencing of CFTR
induced an inflammatory phenotype and augmented apoptosis
that were at least partially regulated by SREBP-mediated Cav1
expression. These findings suggest that defective CFTR in AM is
relevant for the inflammation in CF lung disease.
Materials and Methods
Ethics Statement
Bronchoalveolar lavage (BAL) was performed in 42 clinical
healthy volunteers (average 48612 years, age range 24–79, 31
males and 11 females). Informed consent in written form was
obtained from all volunteers according to Institutional Review
Board (IRB) guidelines and was approved by the ethics committee
of Weill Cornell Medical College (IRB protocol number:
0005004439).
Cells
Human alveolar macrophages (AM) were obtained by BAL [42]
and were processed and cultured as described [13]. Briefly, the
lavage fluid was filtered through one layer of gauze, centrifuged
(400 g, 10 min) and washed three times in PBS, pH 7.4
(Invitrogen, Carlsbad, CA). Cells were then suspended in full
RPMI 1640 medium containing 10% fetal bovine serum, 50 U/
ml penicillin, 50 U/ml streptomycin and 2 mM glutamine
(Invitrogen) and plated. Macrophage content (always .90%)
was determined by Giemsa stain on cytospin preparations (Block
Scientific, Inc., Bohemia, NY). Cell viability (always .90%) was
determined by trypan blue exclusion. The cells were washed after
3 h to remove non-adherent cells.
CFTR Knockdown in AM
Five siRNAs specific pre-designed for CFTR were purchased
(AM16708A, #1 ID: 145572, #2 ID: 104325, #3 ID: 104323,
#4 ID: 4110, #5 ID: 3920; Applied Biosystems, Foster city, CA).
To evaluate the siRNA transfection and knockdown efficacy, AM
were transfected with different doses of pre-designed GAPDH
gene specific siRNA (AM4390850, Applied Biosystems) in siPort as
transfection reagent (Applied Biosystems). Transfection with a
scrambled siRNA (AM4611, Applied Biosystems) was used as
control. After the optimization of siRNA transfection, 100 nM
pre-designed CFTR gene specific siRNA (#4 ID: 4110) was
selected for the transfection to knockdown of CFTR in AM.
The mRNA levels of CFTR in AM transfected with siRNAs
were measured by real-time RT-PCR. RNA was extracted after
48 h from AM transfected with CFTR-siRNA or control-siRNA
using TRIzol (Invitrogen). Following reverse transcription of 2 mg
RNA, CFTR mRNA was amplified by real-time RT-PCR using a
CFTR specific probe (Hs00357011_m1, Applied Biosystems).
CFTR mRNA levels were quantified using the DDCt method
(Applied Biosystems) and normalized relative to 18s ribosomal
RNA (Applied Biosystems). PCR reactions for CFTR and 18s
ribosomal RNA were optimized to yield equal amplification
efficiency. CFTR protein expression was determined by Western
analysis. Total cellular fractions were prepared from AM
transfected CFTR-siRNA and control-siRNA after 48 h. Follow-
ing determination of protein concentration (Micro BCA
TM Protein
Assay Kit; PIERCE, IL), 100 mg protein was separated by
electrophoresis on 4–12% Bis-Tris Gel (NuPAGE@Novex,
Invitrogen), transferred to a polyvinylidene difluoride (PVDF)
membrane (Bio-Rad Laboratories, Hercules, CA) and incubated
with a mouse anti-CFTR antibody (1:1000, R&D System,
Minneapolis, MN). A horseradish peroxidase-conjugated goat
anti-mouse secondary antibody (1:10000, Bio-Rad Laboratories)
and Amersham ECL Plus Western Blotting System (GE
Healthcare Bio-Sciences, Piscataway, NJ) were used for detection.
Following stripping of the membrane, anti-b-tubulin antibody
(1:1000, Sigma-Aldrich, St. Louis, MO) was added to detect b-
tubulin as endogenous control. Expression levels of CFTR relative
to b-tubulin were quantified using Image J software [43].
Inflammatory Response
To evaluate if decreased expression of CFTR results in a pro-
inflammatory phenotype, we analyzed secreted IL-8 levels and
expression of NF-kB in AM transfected with CFTR-siRNA. IL-8
was determined in the culture medium at 0, 2, 4, 8, 24, 48, and
72 h after transfection by ELISA (R&D System), and three
measurements were made for each time point. Protein expressions
of phosphorylated NF-kB and IkB-a were quantified with CFTR
knockdown after 48 h by Western analysis. Fifty mg protein was
separated by electrophoresis on 4–12% Bis-Tris Gel (NuPA-
GE@Novex, Invitrogen), transferred to a PVDF membrane (Bio-
Rad Laboratories) and incubated respectively with a mouse anti-
phospho-NF-kB p65 antibody (1:1000, Cell Signaling Technology,
Inc., Boston, MA) and with a mouse anti-IkB-a antibody (1:1000,
Cell Signaling Technology, Inc.), and normalized to b-tubulin
expression as outlined above.
Apoptosis
To analyze if AM with decreased CFTR are more susceptible to
apoptosis, apoptosis was evaluated by situ terminal deoxynucleoti-
dyltransferase (TUNEL) assay and cleavage of poly (ADP-ribose)
polymerase (PARP). AM, plated on coverslip dishes at a density
5610
5/well were transfected with CFTR-siRNA or control-siRNA.
Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) after
48 h for 15 min, permeabilized with 0.2% Triton X-100 (Sigma-
Aldrich) for 5 min and DNA strand breaks were detected using
flurorescein thiocyanate conjugated dUTP. Nuclei were counter-
stained with 49-6-Diamidino-2-phenylindole (DAPI) (Sigma-Al-
drich). The numberof apoptotic cellswasdetermined by fluorescent
microscopy (Nikon Instruments, NY) by counting 10 fields. Cleaved
PARP protein expression was determined in the cell lysates by
Western analysis. Fifty mg protein was separated by electrophoresis
on 4–12% Bis-Tris Gel (NuPAGE@Novex, Invitrogen), transferred
to a PVDF membrane (Bio-Rad Laboratories) and incubated with a
rabbit anti-PARP antibody (1:200, Santa Cruz Biotechnology, Inc.)
and normalized to b-tubulin expression as outlined above.
Cav1 Expression
To analyze if Cav1, a membrane lipid raft protein, that has been
postulated to be colocalized withCFTR in epithelial cells and that is
related to inflammation and apoptosis in macrophages, is affected
by decreased CFTR expression in AM, we evaluated Cav1 RNA
and protein levels. AM were transfected by CFTR-siRNA or
control-siRNA and protein and RNA extracted after 48 h as
described above. The mRNA of Cav1 was amplified by real-time
RT-PCR using a Cav1 specific probe (Hs00184697_m1, Applied
Biosystems). Cav1 protein levels were measured by Western
analysis. Fifty mg protein was separated by electrophoresis on 4–
CFTR in Alveolar Macrophages
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PVDF membrane (Bio-Rad Laboratories) and incubated with a
rabbit anti-Cav1 antibody (1:200, Santa Cruz Biotechnology, Inc.)
and normalized to b-tubulin expression as outlined above.
SREBP Expression and Activity
As Cav1 is related to lipid metabolism in macrophages, and the
SREBP is known to be a major regulator of Cav1 expression, we
evaluated expression and activity of SREBP in the AM with
CFTR knockdown. Protein expression of SREBP was assessed in
AM transfected with CFTR-siRNA or control-siRNA by Western
analysis. Fifty mg of total cellular protein was loaded on 4–12%
Bis-Tris Gel (NuPAGE@Novex, Invitrogen), transferred to a
PVDF membrane (Bio-Rad Laboratories) membrane and probed
with rabbit anti-SREBP-1 antibody (1:1000, BD-Pharmingen, San
Diego, CA). Transcriptional activity of SRE was assessed using an
adenovirus vector expressing the SRE-promoter of HMG-CoA
synthase linked to a luciferase reporter gene and an unregulated
nuclear b-galactosidase gene (AdZ-SRE-luc), used to control for
transfection efficiency. AM were transfected with CFTR-siRNA
and control-siRNA for 48 h, and then infected with AdZ-SRE-
Luc at 10
4 pu/cell for 48 h. Luciferase and b-galactosidase
activities were analyzed in the cell lysates by luminometric
luciferase and b-galactosidase assays (both, Stratagene, La Jolla,
CA). Luciferase was quantified in a luminometer (BD-Pharmin-
gen). The b-galactosidase levels were determined in a microplate
luminometer (Bio-Rad Laboratories). Data are expressed as
luciferase activity (RLU) normalized to b-galactosidase activity.
Quantification of Cellular Cholesterol Levels
AM were transfected with CFTR-siRNA and control-siRNA for
48 h. Cell lysates of 5610
5 cells were harvested in PBS. Analysis of
free and total cholesterol was carried out with 2 injections per
sample on a DB17 (0.53-mm ID x 15 mx1 mM) gas-chromatogra-
phy column at 250uC installed in a Hewlett-Packard 5890 gas-
chromatograph equipped with a flame ionization detector (Global
Medical Instrumentation Inc., St. Paul, MN). Lipids were extracted
with hexane:isopropanol (3:2, v/v) containing b-sitosterol (5 mg/
sample) as an internal standard (Sigma-Aldrich). One third of the
extract was used for determination of free cholesterol. The aliquot
was dried down, resuspended in hexane (50 ml) and injected into the
gas chromatograph. Two thirds of the extract were used to
determine total cholesterol after alkaline hydrolysis. To each sample
200 ml KOH (50%, w/v) and 3 ml methanol were added, the
mixture was cappedwith argon,vortexed and incubatedat 80uC for
1 h, followed by lipid extraction using 3 ml of water and 5 ml of
HPLC grade hexane (Sigma-Aldrich). Following centrifugation at
500 g for 5 min the hexane phase wasconcentrated by evaporation,
resuspended in hexane and injected into the gas chromatograph.
The difference between total cholesterol and free cholesterol is
esterified cholesterol, and the mass of cholesterol ester is calculated
as 1.67 x esterified cholesterol.
Statistics
The results are presented as mean 6 standard error of the mean
(SEM). Significance was calculated using the student t-test.
Results
CFTR Knockdown in AM
Efficiency of CFTR knockdown in human AM following
transfection with CFTR specific siRNA (CFTR-siRNA) was
assessed by CFTR mRNA and protein expression. The siRNA
transfection efficiency in AM could be achieved 95% with the
transfection of GAPDH-siRNA labeled with green fluorescence
and knockdown of GAPDH gene measured by real-time PCR was
more than 90% compared to the scrambled control siRNA
(control-siRNA) (data not shown). Forty eight hours after
transfection, CFTR mRNA levels were reduced more than 100-
fold in CFTR-siRNA treated cells compared to the cells
transfected with control-siRNA (p=0.001; Figure 1A). CFTR
protein is known to have an immature form (band B) with the size
of 150 kDa and a fully glycosylated mature form (band C) with the
size of 170 kDa. Our data showed that significant decrease of
immature band B of CFTR protein while the mature form band C
remained unchanged after 48 h CFTR-siRNA transfection
(Figure 1B). The quantification of CFTR protein showed no
decrease of band C (Figure 1C) and a 5.2-fold reduction of band B
(p=0.01; Figure 1D) in AM transfected with CFTR-siRNA
compared to the cells transfected with control-siRNA. The similar
size of CFTR protein was observed in the positive control Calu-3
cell lysate and there was no band in negative control A549 cell
lysate, confirming the specificity of the CFTR antibody (Figure 1B).
Increased Inflammatory Response in AM with CFTR
Knockdown
To analyze if CFTR silencing in human AM affects inflamma-
tory cytokine secretions, IL-8 levels were analyzed in cell culture
supernatants. Compared to human AM transfected with control-
siRNA, IL-8 levels were increased in the supernatant obtained
from human AM transfected with CFTR-siRNA at 24, 36, 48, and
72 h post transfection (p=0.03 at 24 h; p=0.01 at 36 h; p=0.001
at 48 h; p=0.004 at 72 h; Figure 2A). As NF-kB is known to be a
positive regulator of IL-8 secretion we analyzed phosphorylated
NF-kB and IkB-a, one of three inhibitory proteins of NF-kB
activation in the AM with silenced CFTR. Forty eight hours after
transfection, phosphorylated NF-kB, detected at a size of 65 kDa
(Figure 2B), was increased 3.7-fold, as estimated by densitometry
quantification (p=0.01) in human AM transfected with CFTR-
siRNA (Figure 2C). Expression of IkB-a (Figure 2D) was
decreased 1.7-fold (p=0.03) in human AM with silenced CFTR
(Figure 2E). The data suggest that reduced production of CFTR
induces a proinflammatory phenotype in human AM.
Apoptosis in AM with CFTR Knockdown
To assess if the inflammatory phenotype of the AM with
silenced CFTR would affect apoptosis, apoptosis was evaluated by
TUNEL assay and evaluation of caspase-3 mediated cleavage of
poly (ADP-ribose) polymerase (PARP) in human AM 48 h after
transfection with CFTR-siRNA or control-siRNA. Apoptotic cells
were detected by TUNEL assay in AM transfected CFTR-siRNA
(visualized as yellow fluorescence superimposed by blue fluores-
cence DAPI nuclear staining and green TUNEL staining;
Figure 3A) and were increased compared to AM transfected with
control-siRNA (p=0.02; Figure 3B). To correlate the apoptosis
with the proinflammatory phenotype, the proportion of IL-8
secretion to the percentage of non-apoptotic cells was measured in
AM transfected with CFTR-siRNA or control-siRNA. At 48 h,
higher IL-8 production was detected in AM with CFTR
knockdown compared to the control (p=0.04; Figure 3C). The
expression of PARP, a well known apoptosis indicator, was
evaluated by Western analysis. The cleaved form of PARP
(89 kDa) was increased in human AM tranfected with CFTR-
siRNA (Figure 3D). Quantification of PARP protein by densi-
tometry revealed a 3.3-fold increase in human AM transfected
with CFTR-siRNA compared to controls (p=0.01; Figure 3E).
The data suggest that knockdown of CFTR promotes apoptosis in
human AM.
CFTR in Alveolar Macrophages
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We next evalaluated the expression of Cav1, a component of
cellular membrane lipid rafts, that colocalizes with CFTR and is
involved in regulation of inflammatory responses and apoptosis in
macrophages. Forty eight hours after transfection Cav1 mRNA
was increased 2.7-fold (p=0.03) in human AM transfected with
CFTR-siRNA compared to controls transfected with control-
siRNA (Figure 4A). Consistently, protein expression of Cav1,
detected at size of 22 kDa, was increased in human AM tranfected
with CFTR-siRNA compared to controls (Figure 4B). Quantifi-
cation of Cav1 protein expression by densitometry revealed a 2.2-
fold (p=0.02) increase in human AM transfected with CFTR-
siRNA compared to controls (Figure 4C).
SREBP Cleavage and SRE Transcription Activity in AM
with CFTR Knockdown
We next analyzed if the increased Cav1 expression could have
been regulated by SREBP, a known negative regulator of its
transcription and that has been found to be increased in CF
epithelial cells. Expression and activity levels of SREBP in AM
with CFTR knockdown were evaluated by Western analysis and
promoter reporter gene expression. Western analysis, carried out
48 h after transfection, revealed decreased expression of mature
SREBP (mSREBP) (68 kDa), the transcriptionally active protein
that is cleaved, by a multi-step process, from the inactive precursor
from, precursor SREBP (pSREBP) (125 kDa) in human AM
transfected with CFTR-siRNA compared to human AM trans-
fected with control-siRNA (Figure 5A). Concentration of mSREBP
was decreased 2-fold in AM with silenced CFTR (p=0.02;
Figure 5B) as estimated by densitometry. To evaluate SRE-
mediated gene transcription, human AM were transduced with
AdZ-SRE-luc, an Ad vector expressing a luciferase reporter gene
under the control of an SRE-promoter or AdNull, a control
vector. Consistent with decreased mSREBP levels, transcriptional
activity of SRE was reduced in CFTR-deficient human AM
compared to human AM transfected with control-siRNA
(p=0.03; Figure 5C).
SREBP is a key transcription factor of cellular lipid homeostasis
and is usually regulated by altered cellular cholesterol. An altered
cellular cholesterol found in CF epithelial cells has been proposed
to lead to SREBP activation, we determined cellular cholesterol
Figure 1. CFTR knockdown in AM. Human AM, obtained by bronchoalveolar lavage from healthy adults, were transfected with CFTR-siRNA or
control-siRNAandanalyzedafter48 h forCFTR mRNA andprotein byreal-timeRT-PCRandWestern analysis. Toconfirm thespecificity ofCFTRantibody,
A549 cells, which do not have intrinsic CFTR expression, and CFTR expressing cell line Calu-3 cells were used as negative and positive controls in the
Western analysis. A. Real-time RT-PCR. Human 18s ribosomal RNA was used as normalization control. B. Western analysis. B-tubulin or GAPDH was used
as control. CFTR protein was detected as an mmature form (band B) at the size of 150 kDa and a mature form (band C) at the size of 170 kDa. C. and D.
Quantification of Western analysis. Shown is the mean 6 SEM of three pairs of independent samples. This experiment is the representative of 6 studies.
doi:10.1371/journal.pone.0011004.g001
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mass were analyzed by gas chromatography and determined
cholesteryl ester mass by substraction of free cholesterol from total
cholesterol. Total cholesterol and free cholesterol mass were not
different in human AM transfected with CFTR-siRNA or control-
siRNA 48 h or 63 h (data not shown) after transfection
(Figure 5D). We measured de novo synthesis of free cholesterol
by evaluating incorporation of
3H-mevalonolactone into free
cholesterol over 16 h and incorporation of
3H-oleate into
cholesteryl-ester over 4 h and found no difference between both
experimental groups (data not shown). The finding of unaffected
cholesterol mass in the presence of increased Cav1 expression and
decreased mSREBP are consistent with a model in which
knockdown of CFTR in human AM induces a redistribution of
regulatory pools of cholesterol.
Discussion
The contribution of AM to the hyperinflammatory milieu in the
CF lung is not clear. The present study attempts to address this
question by analyzing AM from healthy donors in which
expression of CFTR is decreased by siRNA-mediated knockdown.
AM with decreased CFTR expression exhibited an inflammatory
phenotype as evidence by increased IL-8 and NF-kB, similar to
the phenotype described in epithelial cells that express no or
defective CFTR [44–46]. In contrast to data obtained in epithelial
cells, our results demonstrated an inverse relationship between
expression of CFTR and apoptosis as well as expression of
mSREBP [39]. The data suggest an AM specific phenotype in
which increased expression of Cav1 could be a consequence of
decreased mSREBP and cause for increased apoptosis in this cell
type.
A hyperinflammatory response is a hallmark of CF lung disease
[47]. CFTR-deficient epithelial cells or epithelial cells treated with
CFTR chloride channel inhibitors show increased secretion of IL-
8 [44,46]. Elevated levels of proinflammatory cytokines, such as
IL-8 and IL-6, and decreased levels of the anti-inflammatory
cytokine IL-10 are characteristic findings in the bronchioalveolar
lavage fluid of CF patients even in the absence of pathogens
[1,48,49]. These cytokines are thought to be primarily produced
by the CFTR-deficient epithelial cells, however increased baseline
levels of IL-8 have also been observed in blood monocytes of CF
patients [12] and in AM derived from CF knockout mice [17].
Our results that demonstrate increased secretion of IL-8 and
phosphorylated NF-kB, a positive regulator of IL-8 expression in
human AM obtained from healthy donor in which CFTR
expression was decreased by siRNA-medaited knockdown are
consistent with this shifting paradigm [50]. Increased activation of
NF-kB in CFTR-deficient epithelial cells has been thought to
partially be a result of abnormal trafficking of mutant CFTR
Figure 2. Increased IL-8 secretion of AM with CFTR knockdown. A. AM, transfected with CFTR-siRNA or control-siRNA, were analyzed after 6,
12, 18, 24, 36, 48, and 72 h for IL-8 in the cell culture supernatant by ELISA (* denotes p value: p=0.03 at 24 h; p=0.01 at 36 h; p=0.001 at 48 h;
p=0.004 at 72 h). B. AM, transfected with CFTR-siRNA or control-siRNA after 48 h, were evaluated for phosphorylated NF-kB protein expression of by
Western analysis. C. Quantification of phosphorylated NF-kB Western analysis. D. AM, transfected with CFTR-siRNA or control-siRNA after 48 h, were
also evaluated for IkB-a protein expression of by Western analysis. E. Quantification of IkB-aWestern analysis. Shown is the mean 6 SEM of three
pairs of independent samples. This experiment is the representative of 6 studies.
doi:10.1371/journal.pone.0011004.g002
CFTR in Alveolar Macrophages
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intracellular stress resulting in NF-kB activation [45]. Our findings
suggest that the lack of CFTR in AM alone triggers the
hyperinflammatory response and the activation of NF-kBi nA M
and emphasize the potential significance of this cell type in CF
lung disease.
Figure 3. Increased apoptosis in AM with deficient CFTR. AM transfected with CFTR-siRNA or control-siRNA for 48 h were analyzed for
apoptosis by TUNEL assay and for cleaved PARP protein expression by Western analysis. A. TUNEL assay. The nuclear staining of green fluorescence
was shown as the positive apoptosis signal. DAPI served as normal nuclear staining control. B. Quantification of TUNEL assay. C. IL-8 secretion
adjusted to the percentage of non-apoptotic cells in AM transfected with CFTR-siRNA or control-siRNA after 48 h. D. Western analysis of cleaved
PARP protein expression using b-tubulin as loading control. E. Quantification of Western analysis. Shown is the mean 6 SEM of three pairs of
independent samples. This experiment is the representative of 6 studies.
doi:10.1371/journal.pone.0011004.g003
Figure 4. Cav1 expression is increased in AM with deficient CFTR. AM transfected with CFTR-siRNA or control-siRNA were analyzed for Cav1
mRNA and protein expression after 48 h. A. Real-time RT-PCR. The human 18 s ribosome RNA served as the normalization control. B. Western
analysis. B-tubulin was used as control. C. Quantification of Western analysis. Shown is the mean 6 SEM of three pairs of independent samples. This
experiment is the representative of 6 studies.
doi:10.1371/journal.pone.0011004.g004
CFTR in Alveolar Macrophages
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compared to epithelial cells [11], knockdown by transfection of
CFTR specific siRNA significantly decreased protein expression.
As the half-life of plasma membrane CFTR exceeds 48 h [51], we
did not observe a decrease of the mature form of CFTR. Other
studies using CFTR siRNA also demonstrated the decrease of
single band of CFTR protein [38,52–54], which presumably also
reflects the 150 kDa immature form. Because we could not keep
AM with silenced CFTR in culture for extended periods to see
decreased expression of the mature form of the protein, the
observed effects could reflect the effect of intracellular trafficking
rather than reduced CFTR expression on the cell membrane. In
addition, our model using silencing of CFTR expression for short
term culture may not reflect long term phenotypes of AM in the
lower airways in the CF lung and also does not predict the
phenotype induced by CFTR trafficking mutations such as DF508.
The relationship between CFTR and apoptosis is currently not
clear. Several studies that investigated susceptibility to apoptosis in
cell lines and tissue obtained from CF patients have yielded
inconclusive results [21–30]. On one hand, increased apoptosis
was observed in small intestine biopsies from CF patients [23].
Pancreatic apoptosis, associated with over-expression of IL-8 and
activation of NF-kB pathway, was proposed as a possible
mechanism for CF-related diabetes [21,22]. Other studies
however, did not observe increased baseline apoptosis in
respiratory epithelial cells expressing mutant CFTR except after
exposure of the cells to P. aeruginosa [30].
In contrast, several other studies reported that expression of
defective CFTR or knockdown of CFTR protects against
apoptosis phenotype [24–29]. CF knockout mice exhibited a
baseline proinflammatory state and an anti-apoptotic phenotype in
the pancreas [24] and showed failed induction of apoptosis in
response to P. aeruginosa [28]. Recently, delayed apoptosis has been
described in polymorphonuclear neutrophil (PMN) from CF
patients, which might explain PMN persistence in the CF lung
[29].
Our study showed increased baseline apoptosis in AM with
CFTR knockdown. The increased apoptosis of inflammatory cells
such as macrophages and neutrophils has been considered as an
anti-inflammatory phenotype, however our study showed both
augmented apoptosis and increased proinflammatory in AM with
CFTR knockdown. Altered apoptosis has not been described for
disruption of other epithelial chloride channels, including
members of volume-regulated chloride channel CLC family
[55,56]. We suggested that as a consequence of more proin-
flammatory cytokine production the cells are prone to undergo
apoptosis. Consistent with our findings, increased Cav1 has been
observed in murine peritoneal macrophages undergoing apoptosis
[31]. These contradictory observations could be related to cell
type-specific responses and/or the agents used to induce apoptosis.
Figure 5. Decreased cleavage of the SREBP and transcription activity of SRE in AM with deficient CFTR. A. AM transfected with CFTR-
siRNA or control-siRNA were evaluated after 48 h for SREBP protein expression by Western analysis. B. Quantification of Western analysis. C.
Transcription activity assay of SRE. AM, transfected with CFTR-siRNA for 48 h, were infected with AdZ-SRE-luc. The transcriptional activity of SRE was
measured by luciferase assay using b-gal as normalization control. D. Total cellular cholesterol, free cholesterol, and cholesterol ester were measured
by liquid chromatography. Shown is the mean 6 SEM of three pairs of independent samples. This experiment is the representative of 6 studies.
doi:10.1371/journal.pone.0011004.g005
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may not be accurately predicted by the short term culture results
of our study.
Defective or absent CFTR is known to be associated with
abnormalities in the cellular lipid metabolism [40,57,58]. The
mSREBP and membrane free cholesterol levels have been shown
to be increased in epithelial cells that express defective CFTR [39].
It is, however not clear whether these changes in cholesterol
metabolism are cell-type or CFTR mutation specific, i.e. only
found in cells that express DF508 CFTR protein [37]. Notably,
knockdown of CFTR in human AM did not affect total and free
cellular cholesterol levels in our study. On one hand, the lack of
difference in cholesterol mass could be related to differences in cell
type. In epithelial cells, cholesterol is mainly found in the plasma
membrane, in macrophages, a significant amount of cholesterol
can be found stored in intracellular compartments. Notably,
failure to detect differences in total and free cholesterol mass does
not exclude increased free cholesterol in the plasma membrane,
but is rather supported by the finding of increased Cav1 mass, a
protein known to bind free cholesterol in caveolae.
Increased expression of Cav1 in the present study following
decrease of CFTR expression in AM supports that CFTR and
Cav1 interact in this cell type. Potential explanation for increased
SREBP in CF epithelial cells and decreased SREBP in AM
macrophages that lack CFTR could be that intracellular
cholesterol pools to the decreased mSREBP expression and
decreased SRE activity seen in the AM with decreased CFTR
expression, as Cav1 expression is negatively regulated by SRE in
macrophages. Furthermore, it could also explicate the unchanged
cellular cholesterol levels seen in the present study.
In summary, the present study points to a role in CFTR in AM,
that may be similar to what is known for epithelial cells, as
decreased CFTR expression resulted in an inflammatory cellular
phenotype. In addition, AM with decreased CFTR expression
showed augmented apoptosis, increased expression of Cav1, and
decreased activation of SRE, which may be specific for this cell
type. Lack of CFTR expression in AM may play a role in CF lung
disease and the study of the abnormalities associated with lack of
CFTR expression in this cell type may aid in understanding the
complex cellular functions that CFTR is involved in.
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